Ruff Shamim
- SEC CIK
- 0001685986
No open-market purchases or sales filed in the past year.
Current role at each company
- RETA Reata Pharmaceuticals IncDirectoras of Sep 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ruff Shamim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | Ruff ShamimDirector | SSaleClass A common stock | −8.23K | $164.53 | −$1.35M | −52.8%7.36K after | 10b5-1 |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Ruff ShamimDirector | SSaleClass A common stock | −5.74K | $83.73 | −$480.6K | −52.4%5.22K after |